Sociedad Americana de Hirudoterapia

Leech Histamine-like Vasodilator

Histamine-receptor-acting compound — contributes to local vasodilation at feeding site.

Preclínico / mecanísticoLast updated: 2026-05-26 · Reviewed by ASH Editorial Board
Molecular weight of Leech Histamine-like Vasodilator compared with other characterized leech-derived compoundsHementerin80 kDaHementin80 kDaHementin-Like Protein (HLP-1)80 kDaLeech Collagenase70 kDaHaemadipsa yanyuanensis Progr…70 kDaLeech Apyrase67 kDaCalin65 kDaHyaluronidase60 kDaAntithrombin III binding prot…58 kDaCollagenolytic Fibrinolysin55 kDaLeech Thrombospondin-Like Pro…50 kDaLeech Histamine-like Vasodila…0.2 kDa
Molecular weight (kilodaltons) of Leech Histamine-like Vasodilator (highlighted) alongside other characterized leech salivary compounds. Smaller proteins/peptides generally diffuse and act faster.

Mechanistic Evidence Box

Preclinical / mechanistic
Page type
Compound profile
Evidence type
Histamine-receptor-acting compound — contributes to local vasodilation at feeding site.
Evidence level
Mechanistic discussion
Drug vs leech
Leech-derived crude extract
Safety domains
Allergy / anaphylaxis

Clinical translation limit

Leech-derived histamine-like vasodilator activity is mechanistic only and does NOT establish any clinical therapeutic role. The histaminergic mechanism is relevant to understanding allergic/anaphylactic risk of leech application, not to claims of vasodilator efficacy.

Molecular Profile

Category
Vasodilator
Evidence tier
Preclinical
Molecular weight
200 Da
Source species
Hirudo medicinalis
Leech Histamine-like Vasodilator molecular structure

Biological Targets

  • H1 histamine receptor

External Resources

    Related Vasodilator Compounds

    Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.